Literature DB >> 16532497

Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003.

Robert J Applegate1, Matthew T Sacrinty, Michael A Kutcher, Talal T Baki, Sanjay K Gandhi, Renato M Santos, William C Little.   

Abstract

OBJECTIVES: To evaluate the adjusted risk of vascular complications after manual compression and vascular closure devices for femoral artery access site management in a large contemporary cohort, using propensity score analysis.
BACKGROUND: Vascular closure devices (VCD) allow early ambulation after cardiac procedures involving femoral artery access, but whether the benefit of use of vascular closure devices (VCD) is offset by reduced safety in contemporary practice remains uncertain.
METHODS: Twenty one thousand eight hundred and forty one consecutive diagnostic cardiac catheterization (n = 13,124) and percutaneous coronary intervention procedures (n = 8,717) performed via a femoral access at a single site (WFUBMC) between 1998 and 2003 were evaluated. VCD's were used based on operator preference. Propensity to receive a vascular closure device (VCD) was calculated. The relative incidence of vascular complications was evaluated by logistic regression models, using the propensity score as a covariate.
RESULTS: Overall, the unadjusted incidence of any vascular complication was 1.3% for VCD use and 1.4% for manual compression, p = NS. The propensity score-adjusted odds ratio for any vascular complication comparing VCD (n = 8,707) to manual compression (n = 13,034) was 0.86 (0.67-1.11) for all procedures, 0.80 (0.53-1.21) for diagnostic procedure, and 0.90 (0.65-1.26) for interventional procedures.
CONCLUSIONS: In this large single-center, contemporary observational study, the risk-adjusted occurrence of vascular complications following VCD use for femoral artery access management is not increased by VCD use. Thus, in the current era, the benefit of VCD use is not offset by reduced safety.

Entities:  

Mesh:

Year:  2006        PMID: 16532497     DOI: 10.1002/ccd.20677

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  8 in total

1.  Immediate catheterization laboratory management of acute femoral artery occlusion due to a vascular closure device.

Authors:  Albert W Chan; Robert I G Brown
Journal:  Can J Cardiol       Date:  2008-08       Impact factor: 5.223

2.  Gender related differences in predictors of vascular complications: role of vessel size and BMI.

Authors:  Bina Ahmed; Stefan Lischke; Mike De Sarno; Leigh Ann Holterman; Faye Straight; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

3.  Comparison of Exo-Seal(®) and Angio-Seal (®) for arterial puncture site closure: A randomized, multicenter, single-blind trial.

Authors:  Johannes Ketterle; Harald Rittger; Inga Helmig; Lutz Klinghammer; Stefan Zimmermann; Wolfgang Hohenforst-Schmidt; Johannes Brachmann; Holger Nef; Stephan Achenbach; Christian Schlundt
Journal:  Herz       Date:  2015-06-13       Impact factor: 1.443

4.  A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.

Authors:  Frederic S Resnic; Nipun Arora; Michael Matheny; Matthew R Reynolds
Journal:  Am J Cardiol       Date:  2007-01-22       Impact factor: 2.778

5.  Vascular closure device failure: frequency and implications: a propensity-matched analysis.

Authors:  Sripal Bangalore; Nipun Arora; Frederic S Resnic
Journal:  Circ Cardiovasc Interv       Date:  2009-10-27       Impact factor: 6.546

6.  Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure.

Authors:  Claudio Moretti; Giorgio Quadri; Fiorenzo Gaita; Imad Sheiban
Journal:  Heart Int       Date:  2011-06-27

Review 7.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01

8. 

Authors:  Altino Ono Moraes; Rogério Yoshikazu Nabeshima; Ericsson Fernando Viotto; Marcelo Hiroshi Estevam Yoshida; Jihad Mohamad Mansour Abdallah; Patrícia Gaio
Journal:  J Vasc Bras       Date:  2017 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.